norethindrone acetate has been researched along with Activated Protein C Resistance in 2 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Activated Protein C Resistance: A hemostatic disorder characterized by a poor anticoagulant response to activated protein C (APC). The activated form of Factor V (Factor Va) is more slowly degraded by activated protein C. Factor V Leiden mutation (R506Q) is the most common cause of APC resistance.
Excerpt | Relevance | Reference |
---|---|---|
" The aims of the present study were to evaluate a possible dose-response relationship and differential effects of different HT regimens on functionality of the APC system." | 2.73 | Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. ( Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eilertsen, AL | 1 |
Liestøl, S | 1 |
Mowinckel, MC | 2 |
Hemker, HC | 1 |
Sandset, PM | 2 |
Høibraaten, E | 1 |
de Ronde, H | 1 |
Bertina, RM | 1 |
2 trials available for norethindrone acetate and Activated Protein C Resistance
Article | Year |
---|---|
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, | 2007 |
Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Re | 2001 |